tradingkey.logo
搜尋

Biomerica Inc

BMRA
添加自選
1.500USD
-0.090-5.65%
收盤 07-31 16:00美東報價延遲15分鐘
4.54M總市值
虧損本益比TTM

關於 Biomerica Inc 公司

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.

Biomerica Inc簡介

公司代碼BMRA
公司名稱Biomerica Inc
上市日期Mar 17, 1980
CEOIrani (Zackary S)
員工數量53
證券類型Ordinary Share
年結日Mar 17
公司地址17571 Von Karman Avenue
城市IRVINE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編92614
電話19493792875
網址https://biomerica.com/
公司代碼BMRA
上市日期Mar 17, 1980
CEOIrani (Zackary S)

Biomerica Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Zackary S. Irani
Mr. Zackary S. Irani
Chief Executive Officer, Director
Chief Executive Officer, Director
219.13K
+23.96%
Mr. Gary Lu
Mr. Gary Lu
Chief Financial Officer
Chief Financial Officer
64.53K
+61.98%
Mr. David Moatazedi
Mr. David Moatazedi
Independent Director
Independent Director
41.25K
+48.48%
Mr. Eric Chin
Mr. Eric Chin
Independent Director
Independent Director
32.50K
+69.23%
Mr. Allen C. Barbieri
Mr. Allen C. Barbieri
Executive Vice Chairperson of the Board and Corporate Secretary
Executive Vice Chairperson of the Board and Corporate Secretary
--
--
Dr. Jane F. Emerson, M.D., Ph.D.
Dr. Jane F. Emerson, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Scott Madel
Mr. Scott Madel
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Gary M. Huff
Mr. Gary M. Huff
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Zackary S. Irani
Mr. Zackary S. Irani
Chief Executive Officer, Director
Chief Executive Officer, Director
219.13K
+23.96%
Mr. Gary Lu
Mr. Gary Lu
Chief Financial Officer
Chief Financial Officer
64.53K
+61.98%
Mr. David Moatazedi
Mr. David Moatazedi
Independent Director
Independent Director
41.25K
+48.48%
Mr. Eric Chin
Mr. Eric Chin
Independent Director
Independent Director
32.50K
+69.23%
Mr. Allen C. Barbieri
Mr. Allen C. Barbieri
Executive Vice Chairperson of the Board and Corporate Secretary
Executive Vice Chairperson of the Board and Corporate Secretary
--
--
Dr. Jane F. Emerson, M.D., Ph.D.
Dr. Jane F. Emerson, M.D., Ph.D.
Independent Director
Independent Director
--
--

常見問題

Biomerica Inc的前五大股東是誰?

Biomerica Inc的前五大股東如下:Mr. Zackary S. Irani

有多少機構持有Biomerica Inc(BMRA)的股份?

截至2026Q1,共有59家機構持有Biomerica Inc的股份,合計持有的股份價值約為94.38K,占公司總股份的3.05% 。與2025Q4相比,機構持股有所增加,增幅為-250592.00。

哪個業務部門對Biomerica Inc的收入貢獻最大?

在2026Q1,Clinical Lab業務部門對Biomerica Inc的收入貢獻最大,創收676.00K,占總收入的55.87% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有